Skip to main content

Advertisement

Log in

Peripheral Nerve Stimulation for the Treatment of Primary Headache

  • Anesthetic Techniques in Pain Management (K Williams, Section Editor)
  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

A headache is a common neurological disorder, and large numbers of patients suffer from intractable headaches including migraine, tension headache and cluster headache, etc., with no clear therapeutic options. Despite the advances made in the treatment of headaches over the last few decades, subsets of patients either do not achieve adequate pain relief or cannot tolerate the side effects of typical migraine medications. An electrical stimulation of the peripheral nerves via an implantable pulse generator appears to be good alternative option for patients with treatment-refractory headaches. A number of clinical trials show considerable evidence supporting the use of peripheral nerve stimulator (PNS) for headaches not responding to conservative therapies. However, the mechanism by which PNS improves headaches or predicts who will benefit from PNS remains uncertain. The decision to use PNS should be individualized based on patient suffering and disability. Hence, further work is imperative. Here, we discuss the mechanism, indication, efficacy, implant technique, and complications of PNS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Menken M, Munsat TL, Toole JF. The global burden of disease study-implications for neurology. Arch Neurol. 2000;57:418–20.

    Article  PubMed  CAS  Google Scholar 

  2. Stovner L, Hagen K, Jensen R, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27:193–210.

    Article  PubMed  Google Scholar 

  3. Shelden CH. Depolarization in the treatment of trigeminal neuralgia. Evaluation of compression and electrical methods; clinical concept of neurophysiological mechanism. In: Knighton RS, Dumke PR, editors. Pain. Boston: Little, Brown, 1966:373–86.

  4. Wall PD, Sweet WH. Temporary abolition of pain in man. Science. 1967;155:108–9.

    Article  PubMed  CAS  Google Scholar 

  5. Weiner RL, Reed KL. Peripheral neurostimulation for control of intractable occipital neuralgia. Neuromodulation. 1999;2:217–21.

    Article  PubMed  CAS  Google Scholar 

  6. •• Silberstein S, Dodick D, Saper S et al. Safety and Efficacy of Peripheral Nerve Stimulation of the Occipital Nerves for the Management of Chronic Migraine: Results from a Randomized, Prospective, Multicenter, Double-blinded, Controlled Study. Cephalgia. 2012;32(16):1165–79. This article is the first large scale study of PNS of the occipital nerves in migraine patients that showed significant reductions in pain, headache days, and migraine-related disability.

  7. Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150:971–9.

    Article  PubMed  CAS  Google Scholar 

  8. Matharu MS, Bartsch T, Ward N, et al. Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. Brain. 2004;127(Pt 1):220–30.

    Article  PubMed  Google Scholar 

  9. Bartsch T, Goadsby PJ. Stimulation of the greater occipital nerve induces increased central excitability of dural afferent input. Brain. 2002;125:1496–509.

    Article  PubMed  Google Scholar 

  10. Bartsch T, Goadsby PJ. Increased responses in trigeminocervical nociceptive neurones to cervical input after stimulation of the dura mater. Brain. 2003;126:1801–13.

    Article  PubMed  CAS  Google Scholar 

  11. Edvinsson L, Goadsby PJ. Neuropeptides in headache. Eur J Neurol. 1998;5:329–41.

    Article  Google Scholar 

  12. Goadsby PJ, Edvinsson L, Ekman R. Release of vasoactive peptides in the extracerebral circulation of man and the cat during activation of the trigeminovascular system. Ann Neurol. 1988;23:193–6.

    Article  PubMed  CAS  Google Scholar 

  13. Storer RJ, Akerman S, Goadsby PJ. Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat. British J of Pharm. 2004;142:1171–81.

    Article  CAS  Google Scholar 

  14. Iversen HK, Olesen J, Tfelt-Hansen P. Intravenous nitroglycerin as an experimental headache model. Basic characteristics. Pain. 1989;38:17–24.

    Article  PubMed  CAS  Google Scholar 

  15. Afridi S, Kaube H, Goadsby PJ. Glyceryl trinitrate triggers premonitory symptoms in migraineurs. Pain. 2004;110:675–80.

    Article  PubMed  CAS  Google Scholar 

  16. Juhasz G, Zsombok T, Modos EA, et al. NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release. Pain. 2003;106:461–70.

    Article  PubMed  CAS  Google Scholar 

  17. Juhasz G, Zsombok T, Jakab B, et al. Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin-induced migraine attack. Cephalalgia. 2005;25:179–83.

    Article  PubMed  CAS  Google Scholar 

  18. Goadsby PJ, Knight YE, Hoskin KL. Stimulation of the greater occipital nerve increases metabolic activity in the trigeminal nucleus caudalis and cervical dorsal horn of the cat. Pain. 1997;73:23–8.

    Article  PubMed  CAS  Google Scholar 

  19. Hunter CR, Mayfield FH. Role of the upper cervical roots in the production of pain in the head. Am J Surg. 1949;78:743–9.

    Article  PubMed  CAS  Google Scholar 

  20. Kerr FWL. A mechanism to account for frontal headache in cases of posterior fossa tumors. J Neurosurg. 1961;18:605–9.

    Article  PubMed  CAS  Google Scholar 

  21. Piovesan EJ, Stani FD, Kowacs PA, Mulinari RA, Radunz VH, Utiumi M, et al. Massaging over the greater occipital nerve reduces the intensity of migraine attacks. Arq Neuropsiquiatr. 2007;65(3-A):599–604.

    Article  PubMed  Google Scholar 

  22. Le Bars D, Dickenson AH, Besson JM. Diffuse inhibitory controls (DNIC). Effects on dorsal horn convergent neurones in the rat. Pain. 1979;6:283–304.

    Article  PubMed  Google Scholar 

  23. Ellrich J, Treede RD. Characterization of blink reflex interneurons by activation of diffuse noxious inhibitory controls in man. Brain Res. 1998;803:161–8.

    Article  PubMed  CAS  Google Scholar 

  24. Kaube H, Hoskin KL, Goadsby PJ. Activation of the trigeminovascular system by mechanical distension of the superior sagittal sinus in the cat. Cephalalgia. 1992;12:133–6.

    Article  PubMed  CAS  Google Scholar 

  25. Goadsby PJ, Hoskin KL, Knight YE. Stimulation of greater occipital nerve increases metabolic activity in the trigeminal nucleus caudalis and cervical dorsal horn of the cat. Pain. 1997;73:23–8.

    Article  PubMed  CAS  Google Scholar 

  26. Herrero JF, Laird JM, Lopez-Garcia JA. Wind up of spinal cord neurons and pain sensation: much ado about something? Prog Neurobiol. 2000;61:169–203.

    Article  PubMed  CAS  Google Scholar 

  27. Magis D, Bruno MA, Fumal A, Gerardy PY, Hustinx R, Laureys S, et al. Central modulation in cluster headache patients treated with occipital nerve stimulation: an FDG-PET study. BMC Neurol. 2011;11:25.

    Article  PubMed  Google Scholar 

  28. Thimineur M, Ridder D. C2 area neuromodulation: a surgical treatment for fibromyalgia. Pain Med. 2007;8:639–46.

    Article  PubMed  Google Scholar 

  29. Headache Classification Committee of the International Headache Society. The international classification of headache disorders. Cephalalgia. 2004;24 Suppl 1:9–160.

    Google Scholar 

  30. Schulman EA, Lake AE, Goadsby PJ, et al. Defining refractory migraine and refractory chronic migraine: proposed criteria from the refractory headache special interest section of the American headache society. Headache. 2008;48:778–82.

    Article  PubMed  Google Scholar 

  31. Goadsby PJ, Schoenen J, Ferrari MD, et al. Towards a definition of intractable headache for use in clinical practice and trials. Cephalalgia. 2006;26:1168–70.

    Article  PubMed  CAS  Google Scholar 

  32. Jenkins B, Tepper SJ. Neurostimulation for primary headache disorders: part 2, review of central neurostimulators for primary headache, overall therapeutic efficacy, safety, cost, patient selection, and future research in headache neuromodulation. Headache. 2011;51:1408–18.

    Article  PubMed  Google Scholar 

  33. Schwedt TJ, Dodick DW, Trentman TL, et al. Response to occipital nerve block is not useful in predicting efficacy of occipital nerve stimulation. Cephalgia. 2007;27:271–4.

    Article  CAS  Google Scholar 

  34. Lee PB, Huh BK, Pham NK. Long term follow up of peripheral nerve stimulation (PNS) for refractory chronic headache: A retrospective review of efficacy and safety of peripheral nerve stimulation [Abstract A204]. Presented at ASA annual meeting. Oct 13–16, 2012.

  35. Barolat G, Ketcik B, He J. Long-term outcome of spinal cord stimulation for chronic pain management. Neuromodulation. 1998;1:19–29.

    Article  PubMed  CAS  Google Scholar 

  36. Burchiel KJ, Anderson VC, Wilson BJ, Denison DB, Olson KA, Shatin D. Prognostic factors of spinal cord stimulation for chronic back and Leg pain. Neurosurgery. 1995;36:1101–10.

    Article  PubMed  CAS  Google Scholar 

  37. Trentman TL, Zimmerman RS. Occipital nerve stimulation: technical and surgical aspects of implantation. Headache. 2008;48:319–27.

    Article  PubMed  Google Scholar 

  38. Kapural L, Mekhail N, Hayek SM, Stanton-Hicks M, Malak O. Occipital nerve electrical stimulation via the midline approach and subcutaneous surgical leads for treatment of severe occipital neuralgia: a pilot study. Anesth Analg. 2005;101:171–4.

    Article  PubMed  Google Scholar 

  39. Trentman TL, Slavin KV, Freeman JA, Zimmerman RS. Occipital nerve stimulator placement via a retromastoid to infraclavicular approach: a technical report. Stereotact Funct Neurosurg. 2010;88:121–5.

    Article  PubMed  Google Scholar 

  40. Shin JH, Kim YC, Jang IK, Kim JH, Park SY, Lee SC. Occipital nerve stimulation in a patient with an intractable chronic headache – a case report. KJA. 2011;60:298–301.

    Google Scholar 

  41. Oh MY, Ortega J, Bellotte JB, Whiting DM, Alo KM. Peripheral nerve stimulation for the treatment of occipital neuralgia and transformed migraine using a C1-2-3 subcutaneous paddle style electrode: a technical report. Neuromodulation. 2004;7:103–12.

    Article  PubMed  Google Scholar 

  42. Slavin KV, Colpan ME, Munawar N, Wess C, Nersesyan H. Trigeminal and occipital peripheral nerve stimulation for craniofacial pain: a single institution experience and review of the literature. Neurosurg Focus. 2006;21(E6):1–5.

    Article  Google Scholar 

  43. Melvin Jr EA, Jordan FR, Weiner RL, Primm D. Using peripheral stimulation to reduce the pain of C2 mediated occipital headaches: a preliminary report. Pain Physician. 2007;10:453–60.

    PubMed  Google Scholar 

  44. Falowski S, Wang D, Sabesan A, Sharan A. Occipital nerve stimulator systems: review of complications and surgical techniques. Neuromodulation. 2010;13:121–5.

    Article  PubMed  Google Scholar 

  45. Schwedt TJ, Dodick DW, Trentman TL, Zimmerman RS. Occipital nerve stimulation for chronic headache –long term safety and efficacy. Cephalalgia. 2007;27:153–7.

    Article  PubMed  CAS  Google Scholar 

  46. Burher AH, Barnett AH, Barnett CF, Obray JB, Mauck WD. Introduction of infection control measures to reduce infection associated with implantable pain therapy devices. Pain Pract. 2007;7:279–84.

    Article  Google Scholar 

  47. Antibiotic prophylaxis for surgery. Treatment guidelines. The Medical Letter. 2004,2(20):27–32.

    Google Scholar 

  48. Antimicrobial prophylaxis in surgery. The Medical Letter. 2001; 43(W1116-1117B):92–8.

  49. Therapeutic Guidelines on Antimicrobial Prophylaxis in Surgery. Am J Health Syst Pharm. 1999;56:1839–88.

    Google Scholar 

  50. Waddell TK, Rotstein OD. Antimicrobial prophylaxi in surgery (clinical practice guidelines). Can Med Assoc J. 1994;151(7):925–31.

    Google Scholar 

  51. Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the national surgical infection prevention project. Am J Surg. 2005;189:395–404.

    Article  PubMed  Google Scholar 

  52. Antibiotic prophylaxis in surgery. Available at http://www.surgicalcriticalcare.net/ Guidelines/antibiotic_prophylaxis.pdf. Accessed September 2012.

  53. Weiner RL, Alo KM, Reed KL, Fuller ML. Subcutaneous neurostimulation for intractable C-2 mediated headaches. J Neurosurg. 2001;94:398A (Abstract).

    Google Scholar 

  54. Popency CA, Alo KM. Peripheral neurostimulation for the treatment of chronic, disabling transformed migraine. Headache. 2003;43:369–75.

    Article  Google Scholar 

  55. • Saper JR, Dodick DW, Silberstein SD, McCarville S, Sun M, Goadsby PJ. Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia. 2010;31:271–85. The data from this feasibility study suggest occipital nerve stimulation for medically intractable chronic migraine headache can be carried out safely and is worthy of further study for this indication. Moreover, study suggested that the response to occipital nerve block may not predict treatment outcomes of occipital nerve stimulation in primary headache.

  56. Reed KL, Black SB, Banta CJ, Will KR. Combined occipital and supraorbital neurostimulation for the treatment of chronic migraine headaches: initial experience. Cephalgia. 2010;30:260–71.

    CAS  Google Scholar 

  57. Magis D, Allena M, Bolla M, Pasqua VD, Remacle JM, Schoenen J. Occipital nerve stimulation for drug resistant chronic cluster headache: a prospective pilot study. Lancet Neurol. 2007;6:314–21.

    Article  PubMed  Google Scholar 

  58. Magis D, Gerardy PY, Remacle JM, Schoenen J. Sustained effectiveness of occipital nerve stimulation in drug resistant chronic cluster headache. Headache. 2011;51:1191–201.

    Article  PubMed  Google Scholar 

  59. Burns B, Watkins L, Goadsby PJ. Treatment of intractable chronic cluster headache by occipital nerve stimulation: long term follow up of eight patients. Lancet. 2007;369:1099–106.

    Article  PubMed  Google Scholar 

  60. Amin S, Buvanendran A, Park KS, Kroin JS, Moric M. Peripheral nerve stimulator for the treatment of supraorbital neuralgia: a retrospective case series. Cephalalgia. 2008;28:355–9.

    Article  PubMed  CAS  Google Scholar 

  61. Dunteman E. Peripheral nerve stimulation for unremitting ophthalmic post herpetic neuralgia. Neuromodulation. 2002;5:32–7.

    Article  PubMed  Google Scholar 

Download references

Disclosure

Dr. Billy Huh is consultant for St. Jude Medical and Boston Scientific. Dr. Pyungbok Lee reported no potential conflicts of interest relevant to this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Billy K. Huh.

Additional information

This article is part of the Topical Collection on Anesthetic Techniques in Pain Management

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, P., Huh, B.K. Peripheral Nerve Stimulation for the Treatment of Primary Headache. Curr Pain Headache Rep 17, 319 (2013). https://doi.org/10.1007/s11916-012-0319-2

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11916-012-0319-2

Keywords

Navigation